參考文獻(xiàn)/References:
[1] 中華醫(yī)學(xué)會骨科學(xué)分會.骨質(zhì)疏松性骨折診療指南(2022年版)[J].中華骨科雜志,2022,42(22):1473-1491.
[2] 中國康復(fù)醫(yī)學(xué)會骨質(zhì)疏松預(yù)防與康復(fù)專業(yè)委員會.骨質(zhì)疏松性椎體壓縮骨折診治專家共識(2021版)[J].中華醫(yī)學(xué)雜志,2021,101(41):3371-3379.
[3] 陳晨,安忠誠,吳連國,等.椎體強(qiáng)化術(shù)后早期與后期殘留腰背痛的原因分析[J].中國骨傷,2022,35(8):724-731.
[4] 劉晨,胡鋮哲,尹遜,等.骨質(zhì)疏松性胸腰椎壓縮骨折經(jīng)皮椎體強(qiáng)化治療后殘余痛的危險(xiǎn)因素[J].中國組織工程研究,2022,26(18):2900-2905.
[5] 劉暢,李大同,劉元,等.急性癥狀性骨質(zhì)疏松性胸腰椎壓縮骨折椎體強(qiáng)化手術(shù)后療效欠佳:與骨水泥、骨密度、鄰近骨折的關(guān)系[J].中國組織工程研究,2021,25(22):3510-3516.
[6] 黃天霽,張施洋,魯超.椎體壓縮骨折行椎體強(qiáng)化術(shù)后中期止痛效果不佳的原因分析[J].重慶醫(yī)學(xué),2018,47(34):4403-4405.
[7] 陳晨,安忠誠,張英健,等.椎體強(qiáng)化術(shù)后殘留腰背痛的研究進(jìn)展[J].中醫(yī)正骨,2020,32(5):26-30.
[8] FAN X,LI S,ZENG X,et al.Risk factors for thoracolumbar pain following percutaneous vertebroplasty for osteoporotic vertebral compression fractures[J/OL].J Int Med Res,2021,49(1):300060521989468[2022-12-25].https://pubmed.ncbi.nlm.nih.gov/33513025/.
[9] PERIS P,BLASCO J,CARRASCO J L,et al.Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment[J].Calcif Tissue Int,2015,96(2):89-96.
[10] 田保磊,姚嘯生,戚曉楠,等.椎體強(qiáng)化術(shù)術(shù)后殘余腰背痛的影響因素及防治措施[J].中國醫(yī)藥導(dǎo)報(bào),2019,16(32):27-29.
[11] HAAS A V,CONG E,SIMPSON C A,et al.Associations among circulating colony-stimulating factor-1,estrogen,and bone mineral density in postmenopausal women:results from a randomized placebo-controlled trial[J].Menopause,2018,25(2):197-201.
[12] 沈煜,馮明利,徐軍,等.老年骨質(zhì)疏松性椎體壓縮性骨折部位和腰椎骨密度對下腰部疼痛的影響[J].中華醫(yī)學(xué)雜志,2016,96(23):1818-1820.
[13] 魯玉州,王雨,王金國,等.針刺聯(lián)合常規(guī)治療對骨質(zhì)疏松性椎體壓縮骨折PVP術(shù)后殘余腰背痛的臨床研究[J].湖北中醫(yī)雜志,2022,44(9):33-36.
[14] PINCUS T,BURTON A K,VOGEL S,et al.A systematic review of psychological factors as predictors of chronicity/disability in prospective cohorts of low back pain[J].Spine(Phila Pa 1976),2002,27(5):E109-120.
[15] YAN Y,XU R,ZOU T.Is thoracolumbar fascia injury the cause of residual back pain after percutaneous vertebroplasty?A prospective cohort study[J].Osteoporos Int,2015,26(3):1119-1124.
[16] 林渺滿,文雪梅,黃宗偉,等.骨質(zhì)疏松性椎體壓縮骨折椎體強(qiáng)化術(shù)后殘余腰背痛風(fēng)險(xiǎn)預(yù)測模型的構(gòu)建與驗(yàn)證[J].中國脊柱脊髓雜志,2022,32(8):720-728.
[17] 王明遠(yuǎn),高云,張帥,等.骨質(zhì)疏松性椎體壓縮骨折PVP、PKP并發(fā)癥防治的進(jìn)展[J].頸腰痛雜志,2022,43(3):434-436.
[18] HU L,SUN H,WANG H,et al.Cement injection and postoperative vertebral fractures during vertebroplasty[J].J Orthop Surg Res,2019,14(1):228.
[19] 賀雙軍,呂南寧,劉昊,等.經(jīng)皮椎體后凸成形術(shù)骨水泥分布形態(tài)對術(shù)后早期療效的影響[J].中華骨科雜志,2019,39(3):137-143.
[20] 周健,董健.椎體強(qiáng)化手術(shù)治療骨質(zhì)疏松性脊柱壓縮骨折并發(fā)癥的再認(rèn)識[J].中國骨傷,2022,35(8):707-709.
[21] ZHANG Z F,LIU D H,WU P Y,et al.Ultra-early injection of low-viscosity cement in vertebroplasty procedure for treating osteoporotic vertebral compression fractures:a retrospective cohort study[J].Int J Surg,2018,52:35-39.
[22] CHEN L H,HSIEH M K,LIAO J C,et al.Repeated percutaneous vertebroplasty for refracture of cemented vertebrae[J].Arch Orthop Trauma Surg,2011,131(7):927-933.
[23] 李秋江,房曉敏,王胤斌,等.骨質(zhì)疏松性椎體壓縮性骨折椎體強(qiáng)化術(shù)后椎體再骨折的相關(guān)因素[J].中華骨質(zhì)疏松和骨礦鹽疾病雜志,2021,14(3):252-260.
[24] 李正,付軍.唑來膦酸和特立帕肽對預(yù)防椎體成形術(shù)后再發(fā)骨折的療效比較[J].中國骨質(zhì)疏松雜志,2019,25(7):1002-1005.
[25] 田保磊,姚嘯生,戚曉楠,等.椎體強(qiáng)化術(shù)后鄰椎再發(fā)骨折影響因素及預(yù)防研究進(jìn)展[J].中國中醫(yī)骨傷科雜志,2019,27(1):82-85.
[26] WANG Y T,WU X T,CHEN H,et al.Adjacent-level symptomatic fracture after percutaneous vertebral augmentation of osteoporotic vertebral compression fracture:a retrospective analysis[J].J Orthop Sci,2014,19(6):868-876.
[27] 孟勝偉,蔣盛旦,蔣雷生.胸腰椎骨質(zhì)疏松性椎體壓縮性骨折椎體強(qiáng)化術(shù)后腰背痛原因的研究進(jìn)展[J].脊柱外科雜志,2017,15(2):117-122.
[28] 張永遠(yuǎn),孫宏慧,郝定均.脊柱化膿性感染的診斷和治療進(jìn)展[J].中國脊柱脊髓雜志,2019,29(8):747-751.
[29] 劉永強(qiáng),周紀(jì)平.Kümmell病的臨床研究進(jìn)展[J].中國矯形外科雜志,2023,31(3):242-246.
[30] 趙鵬,慈元,李志君,等.經(jīng)椎間孔入路椎體成形術(shù)治療Kümmell病的臨床療效[J].中國脊柱脊髓雜志,2020,30(2):184-188.
[31] 郝定均,劉鵬,賀寶榮,等.陳舊性與新鮮性壓縮骨折行椎體成形術(shù)的臨床對比研究[J].脊柱外科雜志,2012,10(2):83-86.